Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - capsules hard - 67 milligram - fibrates - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following:
treatment of severe hypertriglyceridaemia with or without low hdl cholesterol.
mixed hyperlipidaemia when a statin is contraindicated or not tolerated.
mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine hydrochloride - tablets - 8 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine hydrochloride - tablets - 16 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - eprosartan mesylate - film coated tablet - 400 milligram - angiotensin ii antagonists, plain - angiotensin-ii antagonists, plain c - eprosartan is indicated for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - eprosartan mesylate - film coated tablet - 600 milligram - angiotensin ii antagonists, plain - angiotensin-ii antagonists, plain c - eprosartan is indicated for the treatment of essential hypertension

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - eprosartan mesylate, hydrochlorothiazide - film coated tablet - 600/12.5 milligram - eposartan and diuretics - angiotensin-ii antagonists, plain c - essential hypertension it is indicated in patients whose blood pressure is not adequately controlled on eprosartan alone.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine dihydrochloride - tablets - 8 milligram - antivertigo preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine dihydrochloride - tablets - 16 milligram - antivertigo preparations